Patents Represented by Attorney Jerry J. Filcik Julius P. Yetter
  • Patent number: 4137309
    Abstract: Organophosphonate compounds are used in the treatment of sickle cell anemia and other hemoglobinopathies, as well as attendant peripheral vascular diseases.
    Type: Grant
    Filed: October 14, 1976
    Date of Patent: January 30, 1979
    Assignee: The Procter & Gamble Company
    Inventor: Barry F. Van Duzee